- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
- 1 x RAM: alpha-L-rhamnopyranose(Non-covalent)
RAM.3: 13 residues within 4Å:- Chain A: E.89, G.92, V.93, L.94, M.178, N.236, V.239, S.240, I.243
- Ligands: DEB.2, FMT.8, FMT.9, FMT.45
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.239, A:I.243
- Hydrogen bonds: A:E.89, A:E.89, A:V.93, A:L.94, A:N.236, A:S.240
- Water bridges: A:Q.193
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 41 x FMT: FORMIC ACID(Non-functional Binders)
FMT.5: 4 residues within 4Å:- Chain A: R.62, I.63, G.66, H.351
Ligand excluded by PLIPFMT.6: 4 residues within 4Å:- Chain A: D.169, R.172, T.173, D.176
Ligand excluded by PLIPFMT.7: 3 residues within 4Å:- Chain A: A.187, E.188, R.191
Ligand excluded by PLIPFMT.8: 8 residues within 4Å:- Chain A: E.89, G.92, A.95, F.296
- Ligands: DEB.2, RAM.3, FMT.9, FMT.45
Ligand excluded by PLIPFMT.9: 8 residues within 4Å:- Chain A: F.84, T.86, P.88, E.89, Q.193
- Ligands: DEB.2, RAM.3, FMT.8
Ligand excluded by PLIPFMT.10: 3 residues within 4Å:- Chain A: M.58, R.62, V.330
Ligand excluded by PLIPFMT.11: 2 residues within 4Å:- Chain A: T.113, A.114
Ligand excluded by PLIPFMT.12: 6 residues within 4Å:- Chain A: D.67, S.68, F.70, D.97, P.98
- Ligands: FMT.42
Ligand excluded by PLIPFMT.13: 4 residues within 4Å:- Chain A: F.349, H.355, R.363
- Ligands: FMT.44
Ligand excluded by PLIPFMT.14: 3 residues within 4Å:- Chain A: R.35, R.326, E.328
Ligand excluded by PLIPFMT.15: 7 residues within 4Å:- Chain A: S.20, D.26, L.27, D.28, Y.31, R.398
- Ligands: FMT.18
Ligand excluded by PLIPFMT.16: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.17: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.18: 3 residues within 4Å:- Chain A: S.20, L.21
- Ligands: FMT.15
Ligand excluded by PLIPFMT.19: 6 residues within 4Å:- Chain A: R.42, T.51, A.52, W.53, E.315, P.316
Ligand excluded by PLIPFMT.20: 4 residues within 4Å:- Chain A: A.114, E.118, R.121, Q.360
Ligand excluded by PLIPFMT.21: 1 residues within 4Å:- Chain A: E.268
Ligand excluded by PLIPFMT.22: 3 residues within 4Å:- Chain A: D.129, A.372, R.376
Ligand excluded by PLIPFMT.23: 3 residues within 4Å:- Chain A: L.131, D.134, F.147
Ligand excluded by PLIPFMT.24: 1 residues within 4Å:- Chain A: Q.206
Ligand excluded by PLIPFMT.25: 2 residues within 4Å:- Chain A: D.209
- Ligands: FMT.26
Ligand excluded by PLIPFMT.26: 3 residues within 4Å:- Chain A: D.209, P.211
- Ligands: FMT.25
Ligand excluded by PLIPFMT.27: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.28: 5 residues within 4Å:- Chain A: R.172, D.176, H.246, E.247, V.250
Ligand excluded by PLIPFMT.29: 3 residues within 4Å:- Chain A: H.351, G.352, H.355
Ligand excluded by PLIPFMT.30: 1 residues within 4Å:- Ligands: TRS.4
Ligand excluded by PLIPFMT.31: 0 residues within 4Å:- (No contacts)
Ligand excluded by PLIPFMT.32: 4 residues within 4Å:- Chain A: S.68, R.69, E.302
- Ligands: FMT.33
Ligand excluded by PLIPFMT.33: 2 residues within 4Å:- Chain A: E.302
- Ligands: FMT.32
Ligand excluded by PLIPFMT.34: 1 residues within 4Å:- Ligands: FMT.35
Ligand excluded by PLIPFMT.35: 3 residues within 4Å:- Chain A: D.303, E.305
- Ligands: FMT.34
Ligand excluded by PLIPFMT.36: 4 residues within 4Å:- Chain A: A.300, T.301, A.313, G.314
Ligand excluded by PLIPFMT.37: 2 residues within 4Å:- Chain A: P.46, Y.47
Ligand excluded by PLIPFMT.38: 5 residues within 4Å:- Chain A: H.23, V.386, A.387, L.389, W.391
Ligand excluded by PLIPFMT.39: 2 residues within 4Å:- Chain A: E.119, M.120
Ligand excluded by PLIPFMT.40: 1 residues within 4Å:- Chain A: T.310
Ligand excluded by PLIPFMT.41: 3 residues within 4Å:- Chain A: R.343, N.344, P.345
Ligand excluded by PLIPFMT.42: 6 residues within 4Å:- Chain A: V.64, L.65, T.72, R.298, H.354
- Ligands: FMT.12
Ligand excluded by PLIPFMT.43: 2 residues within 4Å:- Chain A: R.123, E.159
Ligand excluded by PLIPFMT.44: 1 residues within 4Å:- Ligands: FMT.13
Ligand excluded by PLIPFMT.45: 7 residues within 4Å:- Chain A: G.92, V.93, L.94, S.240
- Ligands: DEB.2, RAM.3, FMT.8
Ligand excluded by PLIP- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.08 Å
- Oligo State
- monomer
- Ligands
- 1 x HEM: PROTOPORPHYRIN IX CONTAINING FE(Non-covalent)
- 1 x DEB: 6-DEOXYERYTHRONOLIDE B(Non-covalent)
- 1 x RAM: alpha-L-rhamnopyranose(Non-covalent)
- 1 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 41 x FMT: FORMIC ACID(Non-functional Binders)
- 2 x NA: SODIUM ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Parisi, G. et al., Dissecting the Cytochrome P450 OleP Substrate Specificity: Evidence for a Preferential Substrate. Biomolecules (2020)
- Release Date
- 2020-10-21
- Peptides
- Cytochrome P-450: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A